Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care * an implementation pilot

• Conditions: sugar; glucose metabolism disorder; 10018424

• Registration Number: NL-OMON45788
• Lead Sponsor: TNO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

The participants will be recruited from the T2D patient population of healthcare partnership Stevenshof. Four GPA*s work for healthcare partnership Stevenshof. Each GPA will select two T2D patients in each of the two study phases. These patients should meet one of the following requirements:
- Patient is newly diagnosed with T2D
- Patient is about to start Metformin
- Patient is about to start with a second oral drug (like SU-derivates)
- Patient is about to start with an injectable drug (Insulin or GLP-1);Besides that, the patients should meet the following inclusion criteria:
- Aged between 30-80
- Have a BMI between 25-35
- Willing and able to sign the informed consent form
- Able to fill in the 360-degree questionnaire which is in Dutch
- Able to work with computers (e.g. for filling in digital questionnaires)

Exclusion Criteria

A candidate who meets any of the following criteria will be excluded from participation in this study:
- Dialysis patients
- Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
- Patients under treatment of a psychiatrist
- Incapacitated patients
- Patients in a palliative phase

Study & Design

• Study Type: Interventional
• Study Design: Not specified